News & Perspective

Oct 25, 2001

Oct 25, 2001

Studies raise hopes for invention of drugs to block anthrax toxin

Oct 25 (CIDRAP News) – Two studies published online by Nature this week help explain how anthrax toxin works, possibly paving the way for the development of drugs that could block the toxin's action. One group of researchers explains how it identified the cell-surface receptor that enables anthrax toxin to invade host cells, while another group describes the precise molecular structure of a key component of the toxin.

Oct 02, 2003

Oct 02, 2003

NIAID funds further development of new anthrax vaccines

(CIDRAP News) – The federal government awarded two contracts totaling more than $150 million this week for further testing and initial production of new anthrax vaccines designed to be safer and require fewer doses than the existing vaccine.

Nov 17, 2004

Nov 17, 2004

Clinical trials of human H5N1 flu vaccine to start soon

(CIDRAP News) – Clinical trials of a vaccine designed to keep the H5N1 avian influenza virus from sparking a human flu pandemic will begin early in 2005, the head of the National Institute of Allergy and Infectious Diseases (NIAID) said this week.

Dec 14, 2004

Dec 14, 2004

Shortage spurs trial of GlaxoSmithKline flu vaccine

As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.

Aug 16, 2005

Aug 16, 2005

US seeks stockpile of safer smallpox vaccine

Editor's note: This story was revised Aug 17 to add information on funding and a link to the government's request for proposals to supply the vaccine.

(CIDRAP News) – The US government has called for proposals to supply up to 80 million doses of a weakened smallpox vaccine to protect people for whom the conventional vaccine is too risky, according to two vaccine manufacturers.

Oct 28, 2005

Oct 28, 2005

Chiron wins H5N1 vaccine contract; WHO says virus is changing

(CIDRAP News) – The US government has awarded Chiron Corp. a $62.5 million contract to make a vaccine for H5N1 avian influenza as part of efforts to prepare for a possible human flu pandemic.

May 29, 2007

May 29, 2007

Welsh officials announce four H7N2 flu cases, suspect human-to-human transmission

(CIDRAP News) - Four people in Wales and northwest England have tested positive for the low-pathogenic H7N2 avian influenza subtype found last week in chickens at a small farm in Wales, and local public health authorities suspect some degree of human-to-human transmission of the disease.

Sep 25, 2007

Sep 25, 2007

Wisconsin lab broke Ebola rules, watchdog group says

(CIDRAP News) – Researchers at the University of Wisconsin at Madison (UW-Madison) worked on Ebola virus genetic material in a lab that lacked the required security measures, and federal agencies responsible for monitoring compliance didn't notice the problem, a watchdog group that monitors biodefense research safety reported recently.

Oct 04, 2007

Oct 04, 2007

House committee airs safety concerns about biodefense labs

(CIDRAP News) – A US House of Representatives committee today explored problems at the nation's biodefense labs, including a lack of coordinated federal oversight and even a lack of knowledge of how many high-containment labs exist.

These concerns have been highlighted recently by aggressive efforts from the Sunshine Project, a watchdog group that monitors biodefense research safety, and by other media reports.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»